Article Cited by others


Physiological normal levels of androgen inhibit proliferation of prostate cancer cells in vitro

Song Weitao, Khera Mohit

Year : 2014| Volume: 16| Issue : 6 | Page no: 864-868

   This article has been cited by
1 Safety of testosterone therapy in men with prostate cancer
Abraham Morgentaler,Monica Caliber
Expert Opinion on Drug Safety. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Establishment and characterization of a prostate cancer cell line from a prostatectomy specimen for the study of cellular interaction
Ruoxiang Wang,Gina C.-Y. Chu,Xudong Wang,Jason B. Wu,Peizhen Hu,Asha S. Multani,Sen Pathak,Haiyen E. Zhau,Leland W.K. Chung
International Journal of Cancer. 2019;
[Pubmed]  [Google Scholar] [DOI]
3 hASH1 nuclear localization persists in neuroendocrine transdifferentiated prostate cancer cells, even upon reintroduction of androgen
Jennifer A. Fraser,Joseph E. Sutton,Saba Tazayoni,Isla Bruce,Amy V. Poole
Scientific Reports. 2019; 9(1)
[Pubmed]  [Google Scholar] [DOI]
4 Testosterone, testosterone therapy and prostate cancer
A. Yassin,K. AlRumaihi,R. Alzubaidi,S. Alkadhi,A. Al Ansari
The Aging Male. 2019; : 1
[Pubmed]  [Google Scholar] [DOI]
5 The Role of Testosterone Therapy in the Setting of Prostate Cancer
Katherine M. Rodriguez,Alexander W. Pastuszak,Mohit Khera
Current Urology Reports. 2018; 19(8)
[Pubmed]  [Google Scholar] [DOI]
6 Testosterone rapidly increases Ca2+-activated K+ currents causing hyperpolarization in human coronary artery endothelial cells
Katesirin Ruamyod,Wattana B. Watanapa,Chairat Shayakul
The Journal of Steroid Biochemistry and Molecular Biology. 2017;
[Pubmed]  [Google Scholar] [DOI]
7 Effects of Testosterone on Benign and Malignant Conditions of the Prostate
Amin S. Herati,Taylor P. Kohn,Peter R. Butler,Larry I. Lipshultz
Current Sexual Health Reports. 2017; 9(2): 65
[Pubmed]  [Google Scholar] [DOI]
8 Testosterone inhibits the growth of prostate cancer xenografts in nude mice
Weitao Song,Vikram Soni,Samit Soni,Mohit Khera
BMC Cancer. 2017; 17(1)
[Pubmed]  [Google Scholar] [DOI]
9 Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes
Jesse Ory,Ryan Flannigan,Colin Lundeen,James G. Huang,Peter Pommerville,S. Larry Goldenberg
The Journal of Urology. 2016;
[Pubmed]  [Google Scholar] [DOI]
10 Adult-Onset Hypogonadism
Mohit Khera,Gregory A. Broderick,Culley C. Carson,Adrian S. Dobs,Martha M. Faraday,Irwin Goldstein,Lawrence S. Hakim,Wayne J.G. Hellstrom,Ravi Kacker,Tobias S. Köhler,Jesse N. Mills,Martin Miner,Hossein Sadeghi-Nejad,Allen D. Seftel,Ira D. Sharlip,Stephen J. Winters,Arthur L. Burnett
Mayo Clinic Proceedings. 2016; 91(7): 908
[Pubmed]  [Google Scholar] [DOI]
11 Male hormones and men's quality of life
Mohit Khera
Current Opinion in Urology. 2016; 26(2): 152
[Pubmed]  [Google Scholar] [DOI]
12 Testosterone Therapy Among Prostate Cancer Survivors
Taylor M. Nguyen,Alexander W. Pastuszak
Sexual Medicine Reviews. 2016;
[Pubmed]  [Google Scholar] [DOI]
13 Testosterone Therapy in Men With Prostate Cancer
Alan L. Kaplan,Jim C. Hu,Abraham Morgentaler,John P. Mulhall,Claude C. Schulman,Francesco Montorsi
European Urology. 2015;
[Pubmed]  [Google Scholar] [DOI]
14 Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer
Alexander W. Pastuszak,Abhinav Khanna,Niraj Badhiwala,Abraham Morgentaler,Mariam Hult,William P. Conners,Michael F. Sarosdy,Christopher Yang,Rafael Carrion,Larry I. Lipshultz,Mohit Khera
The Journal of Urology. 2015; 194(5): 1271
[Pubmed]  [Google Scholar] [DOI]
15 Low testosterone level is an independent risk factor for high-grade prostate cancer detection at biopsy
Juhyun Park,Sung Yong Cho,Seung-hwan Jeong,Seung Bae Lee,Hwancheol Son,Hyeon Jeong
BJU International. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
16 Controversies and Advances With Testosterone Therapy: A 40-Year Perspective
Abraham Morgentaler
Urology. 2015;
[Pubmed]  [Google Scholar] [DOI]


Read this article